User Stats

Level: Guru
Member Since: 11/07/2020

Profile Information

First name Nicolás
Last name Damián Servidio
Last Name

Servidio

Help us confirm that you're an expert

I worked as a senior analyst and project manager at Aging Analytics Agency, Deep Knowledge Analytics and Deep Knowledge Ventures (Deep Knowledge Group subsidiaries) conducting industry and markets analysis, and scientific counseling, related to cutting edge tech industry, digital health, biotech, biomedicine, geroscience, pharmaceutical and longevity industries, and intersections with the AI, SaaS, FinTech and Blockchain Industries for the UK APPG for Longevity, United Nations NGO Committee on Ageing, Longevity AI Consortium at King’s College London, Metabesity Conference in Washington D.C., Longevity.International and Longevity.Capital. I have conducted analytics regarding public organisms’ policies and programs, international relations and partnerships, for-profit and non-profit companies, early-stage start-ups and industry giants, the longevity industry and its intersections with the digital industry, translating my work into a set of written and also infographic reports, both open source and proprietary, some of which can be found as a reference in my LinkedIn profile. These reports can be included within what is known as market and investment intelligence. I have conducted direction, management and production of many of those analytical reports and interactive infographic reports, while I have participated as associate analyst and advisor in others . I have developed experience in data mining although I do not use sophisticated and automated procedures; also in production, curation and interpretation of databases; data science, statistics, metrics and indicators. In addition to all these responsibilities, my tasks have involved copywriting, translating, proofreading and design activities.

SOME PROJECTS (some developed entirely on my own):

. Biomarkers of Longevity: Current state, Challenges and Opportunities Landscape Overview 2019
Summary: A special analytical case study ranking and benchmarking existing panels of biomarkers of ageing, health and Longevity according to their ratios of accuracy vs. actionability, identifying which can have the greatest impact on increasing Healthy Longevity. An in-depth review of the state of the art in biomarkers development. Quoted in numerous foreign media, and formally presented at the ‘AI for Longevity Summit 2019’ conference held at King’s College London, November 2019.

. “Longevity Industry 1.0 – Defining the Biggest and Most Complex Industry in Human History” original book
. 1000 Longevity Leaders
. AgeTech UK IT-Platform

. COVID-19 Regional Safety Assessment
Summary: Deep Knowledge Group’s COVID-19 special analytical case study is designed to classify, analyze and rank the economic, social and health stability achieved by 20 regions, as well as their strengths, weaknesses, opportunities, and threats in the battle against the global health and economic crisis triggered by COVID-19.

. COVID-19 MedTech Analytics
Summary: Deep Knowledge Group’s COVID-19 MedTech Analytics IT-Platform is designed to serve as a comprehensive database of the most relevant entities, technologies, and developments in the COVID-19 MedTech ecosystem, aggregating, profiling and visualizing the companies, organizations, scientists and technologies at the forefront of neutralizing the COVID-19 pandemic.

. UK COVID-19 MedTech Ecosystem
Summary: A component of Deep Knowledge Group’s interactive UK COVID-19 MedTech Analytics IT-Platform, which visualizes and categorizes 700+ companies, labs, R&D hubs, universities, investors and funding and support bodies working at the forefront of neutralizing the COVID-19 pandemic.

Outside of my activity in DKG subsidiaries, I am currently an active participant in the blockchain community and an independent retail investor and trader, with plans to venture as an angel investor, also independently and through digital platforms analogous to BnkToTheFuture, looking for early-stage companies determined to carry out a future IPO. I also have academic experience in organometallic chemistry laboratory work tasks as a research student, addressing the identification and purification of novel drugs, and I have completed an internship as Data Science Manager for MAyDS (Argentina), FAO (United Nations Organization) and the Global Environment Facility; this work is linked to invasive alien species and its impact on global and regional economies conducting tasks with databases. Other works and participations can be found on my public LinkedIn profile.

My main objective through all my activity, both in academic training and the business sector, and what also makes me deeply want to establish a link with BioExpert Network and Capital Cell, are my devotion to science and the desire to help science; to the health industry in general terms and the longevity industry more particularly.

How did you hear about us?

As part of my work, and I have found your profile in LinkedIn through a good colleague from my university, who is already part of the BioExpert Network; this has motivated me to contact you.

Base
Name

Nicolás Damián Servidio

Last Name

Servidio

I have professional experience in:

Professional investor, Seed funding, Venture capital, Biotech, Clinical trials, Digital Health, Health tech, Medical Device, Personalised medicine, Predictive medicine, Therapeutics, Wearables, Business strategy, Startups, Technology transfer, medical big data and analytics

Help us confirm that you're an expert

I worked as a senior analyst and project manager at Aging Analytics Agency, Deep Knowledge Analytics and Deep Knowledge Ventures (Deep Knowledge Group subsidiaries) conducting industry and markets analysis, and scientific counseling, related to cutting edge tech industry, digital health, biotech, biomedicine, geroscience, pharmaceutical and longevity industries, and intersections with the AI, SaaS, FinTech and Blockchain Industries for the UK APPG for Longevity, United Nations NGO Committee on Ageing, Longevity AI Consortium at King’s College London, Metabesity Conference in Washington D.C., Longevity.International and Longevity.Capital. I have conducted analytics regarding public organisms’ policies and programs, international relations and partnerships, for-profit and non-profit companies, early-stage start-ups and industry giants, the longevity industry and its intersections with the digital industry, translating my work into a set of written and also infographic reports, both open source and proprietary, some of which can be found as a reference in my LinkedIn profile. These reports can be included within what is known as market and investment intelligence. I have conducted direction, management and production of many of those analytical reports and interactive infographic reports, while I have participated as associate analyst and advisor in others . I have developed experience in data mining although I do not use sophisticated and automated procedures; also in production, curation and interpretation of databases; data science, statistics, metrics and indicators. In addition to all these responsibilities, my tasks have involved copywriting, translating, proofreading and design activities.

SOME PROJECTS (some developed entirely on my own):

. Biomarkers of Longevity: Current state, Challenges and Opportunities Landscape Overview 2019
Summary: A special analytical case study ranking and benchmarking existing panels of biomarkers of ageing, health and Longevity according to their ratios of accuracy vs. actionability, identifying which can have the greatest impact on increasing Healthy Longevity. An in-depth review of the state of the art in biomarkers development. Quoted in numerous foreign media, and formally presented at the ‘AI for Longevity Summit 2019’ conference held at King’s College London, November 2019.

. “Longevity Industry 1.0 – Defining the Biggest and Most Complex Industry in Human History” original book
. 1000 Longevity Leaders
. AgeTech UK IT-Platform

. COVID-19 Regional Safety Assessment
Summary: Deep Knowledge Group’s COVID-19 special analytical case study is designed to classify, analyze and rank the economic, social and health stability achieved by 20 regions, as well as their strengths, weaknesses, opportunities, and threats in the battle against the global health and economic crisis triggered by COVID-19.

. COVID-19 MedTech Analytics
Summary: Deep Knowledge Group’s COVID-19 MedTech Analytics IT-Platform is designed to serve as a comprehensive database of the most relevant entities, technologies, and developments in the COVID-19 MedTech ecosystem, aggregating, profiling and visualizing the companies, organizations, scientists and technologies at the forefront of neutralizing the COVID-19 pandemic.

. UK COVID-19 MedTech Ecosystem
Summary: A component of Deep Knowledge Group’s interactive UK COVID-19 MedTech Analytics IT-Platform, which visualizes and categorizes 700+ companies, labs, R&D hubs, universities, investors and funding and support bodies working at the forefront of neutralizing the COVID-19 pandemic.

Outside of my activity in DKG subsidiaries, I am currently an active participant in the blockchain community and an independent retail investor and trader, with plans to venture as an angel investor, also independently and through digital platforms analogous to BnkToTheFuture, looking for early-stage companies determined to carry out a future IPO. I also have academic experience in organometallic chemistry laboratory work tasks as a research student, addressing the identification and purification of novel drugs, and I have completed an internship as Data Science Manager for MAyDS (Argentina), FAO (United Nations Organization) and the Global Environment Facility; this work is linked to invasive alien species and its impact on global and regional economies conducting tasks with databases. Other works and participations can be found on my public LinkedIn profile.

My main objective through all my activity, both in academic training and the business sector, and what also makes me deeply want to establish a link with BioExpert Network and Capital Cell, are my devotion to science and the desire to help science; to the health industry in general terms and the longevity industry more particularly.

LinkedIn

http://www.linkedin.com/in/nicolas-servidio-del-monte

How did you hear about us?

As part of my work, and I have found your profile in LinkedIn through a good colleague from my university, who is already part of the BioExpert Network; this has motivated me to contact you.